Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026)

Becton Dickinson (BDX) reported Liabilities and Shareholders Equity of $50.8 billion for Q1 2026, down 6.67% year-over-year from $54.5 billion in Q1 2025, and down 7.31% quarter-over-quarter from $54.8 billion in Q4 2025.

Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $50.8 billion in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $50.8 billion, down 6.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $215.9 billion (down 2.75% YoY), and the FY2025 annual result was $55.3 billion, down 3.42% from the prior year.
  • Liabilities and Shareholders Equity slipped to $50.8 billion in Q1 2026 per BDX's latest filing, from $54.8 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $57.3 billion in Q3 2024 and troughed at $50.8 billion in Q1 2026.
  • A 5-year average of $54.0 billion and a median of $54.4 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity grew 8.54% in 2024, then declined 6.67% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $53.1 billion in 2022, then declined by 1.61% to $52.3 billion in 2023, then advanced by 4.57% to $54.7 billion in 2024, then increased by 0.32% to $54.8 billion in 2025, then retreated by 7.31% to $50.8 billion in 2026.
  • Business Quant data shows BDX's Liabilities and Shareholders Equity at $50.8 billion in Q1 2026, $54.8 billion in Q4 2025, and $55.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn 5.10 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.83 Bn
Dec 31, 2025 54.84 Bn
Sep 30, 2025 55.33 Bn
Jun 30, 2025 54.90 Bn
Mar 31, 2025 54.47 Bn
Dec 31, 2024 54.67 Bn
Sep 30, 2024 57.29 Bn
Jun 30, 2024 55.58 Bn
Mar 31, 2024 54.16 Bn
Dec 31, 2023 52.27 Bn
Sep 30, 2023 52.78 Bn
Jun 30, 2023 53.02 Bn
Mar 31, 2023 54.39 Bn
Dec 31, 2022 53.13 Bn
Sep 30, 2022 52.93 Bn
Jun 30, 2022 53.20 Bn
Mar 31, 2022 54.79 Bn
Dec 31, 2021 53.36 Bn
Sep 30, 2021 53.87 Bn
Jun 30, 2021 54.33 Bn